Opaleye Management, Inc.

Opaleye Management, Inc.

Opaleye Management, Inc.

Overview
Date Founded

1996

Headquarters

1 Boston Place,26th floor,Boston, MA 02108-4407

Type of Company

Private

Employees (Worldwide)

3

Industries

Hedge Funds
Investment Services & Portfolio Management

Company Description

Opaleye Management's strategy for managing their fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology and specialty pharmaceutical and device companies, which may include private companies. Typically, these are companies that are developing therapies and treatments intended for humans. The fund focuses its long investments in equity securities of companies that may not be profitable yet but whose share price may grow significantly in the near term or over a 1-2 year or longer period based on their therapeutic development and financial objectives. The fund also aims to actively invest in stock and derivative transactions to profit from binary events, such as clinical data milestones or a US Food and Drug Administration (FDA) regulatory decision. Conversely, the fund seeks opportunities to short securities that have extended valuations relative to the marketplace. Opaleye Management employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition.

Contact Data
Trying to get in touch with decision makers at Opaleye Management, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Axios.com
May 29, 2020
Axios Pro Rata
Executives & Employees

Founder & President

Biotechnology Investment Analyst

Paths to Opaleye Management, Inc.
Potential Connections via
Relationship Science
You
Opaleye Management, Inc.
Advisors & Consultants
Custodian

Interactive Brokers LLC, a subsidiary of Interactive Brokers Group, Inc., is a company headquartered in Washington, DC, specializing in security brokers, dealers, and flotation companies.

Non-Profit Donations & Grants
$1,000 - $2,499
2019
$1,000 - $2,499
2017
$1,000 - $2,499
2016
Investments
Details Hidden

Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA.

Details Hidden

Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA.

Details Hidden

Grupo Osborne SA manufactures and commercializes wines, spirits, and hams. Its brands include Malpica del Tajo, Carlos I, Anis del Mono and Cinco Jotas. The company was founded by Thomas Osborne Mann in 1772 and is headquartered in El Puerto de Santa Maria, Spain.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Opaleye Management, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Opaleye Management, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Opaleye Management, Inc..